Bonsai Biotherapeutics AB
559523-4435ActiveBiotherapeutics operations assumed following major corporate merger completion.
Oversigt
- 10–19
- Medarbejdere
- Ukendt
- Omsætning
- 2025
- Grundlagt
Beskrivelse
The organization detailed here represents the operational successor to Toleranzia AB following a formal merger with Flerie AB. This complex corporate restructuring, finalized in August 2025, involved the dissolution of Toleranzia and the transfer of all its assets and liabilities. These undertakings...
Tags
Nøgleord
Virksomhedsoplysninger
- Branche
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559523443501
Beslutningstagere
Ingen beslutningstagere fundet endnu
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrMoligo Technologies AB
4 medarbejdereMoligo provides ultrapure, long single-stranded DNA synthesis services at scale.
Theralia AB
0 medarbejderePioneering biotech revolutionizing drug delivery via TOUCAN technology.
Cell4Cure AB
Pioneering antigen-specific immune tolerance therapies using engineered dendritic cells.
Disruptive Pharma AB (publ)
5–9 medarbejdereSwedish biotech developing novel kidney disease therapies based on proprietary peptides.
LIDDS AB
1–4 medarbejdereSwedish drug delivery company utilizing proprietary NanoZolid technology platform.
Udforsk mere
Spørgsmål om Bonsai Biotherapeutics AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo